Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 1
2010 1
2011 2
2012 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Validation of a Machine-Learned, Point-of-Care System to IDENTIFY Functionally Significant Coronary Artery Disease.
Stuckey TD, Meine FJ, McMinn TR, Depta JP, Bennett BA, McGarry TF, Carroll WS, Suh DD, Steuter JA, Roberts MC, Gillins HR, Fathieh F, Burton T, Nemati N, Shadforth IP, Ramchandani S, Bridges CR, Rabbat MG. Stuckey TD, et al. Among authors: mcgarry tf. Diagnostics (Basel). 2024 May 8;14(10):987. doi: 10.3390/diagnostics14100987. Diagnostics (Basel). 2024. PMID: 38786284 Free PMC article.
Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
Turco MA, Ormiston JA, Popma JJ, Mandinov L, O'Shaughnessy CD, Mann T, McGarry TF, Wu CJ, Chan C, Webster MW, Hall JJ, Mishkel GJ, Cannon LA, Baim DS, Koglin J. Turco MA, et al. Among authors: mcgarry tf. J Am Coll Cardiol. 2007 Apr 24;49(16):1676-83. doi: 10.1016/j.jacc.2007.01.069. Epub 2007 Apr 6. J Am Coll Cardiol. 2007. PMID: 17448368 Free article. Clinical Trial.
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
Cohen DJ, Lavelle TA, Van Hout B, Li H, Lei Y, Robertus K, Pinto D, Magnuson EA, Mcgarry TF, Lucas SK, Horwitz PA, Henry CA, Serruys PW, Mohr FW, Kappetein AP. Cohen DJ, et al. Among authors: mcgarry tf. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):198-209. doi: 10.1002/ccd.23147. Epub 2011 Sep 26. Catheter Cardiovasc Interv. 2012. PMID: 21542113 Clinical Trial.
TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
Mahmud E, Ormiston JA, Turco MA, Popma JJ, Weissman NJ, O'Shaughnessy CD, Mann T, Hall JJ, McGarry TF, Cannon LA, Webster MW, Mandinov L, Baim DS. Mahmud E, et al. Among authors: mcgarry tf. JACC Cardiovasc Interv. 2009 Mar;2(3):240-52. doi: 10.1016/j.jcin.2008.12.009. JACC Cardiovasc Interv. 2009. PMID: 19463432 Free article.
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program.
Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS. Turco MA, et al. Among authors: mcgarry tf. JACC Cardiovasc Interv. 2008 Dec;1(6):699-709. doi: 10.1016/j.jcin.2008.09.007. JACC Cardiovasc Interv. 2008. PMID: 19463387 Free article. Clinical Trial.
Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents.
Weissman NJ, Turco MA, Ormiston JA, Mann T, Cannon LA, McGarry TF, Webster MW, Hall JJ, Lucca MJ, Mishkel GJ, Wu CJ, Mandinov L, Dawkins KD. Weissman NJ, et al. Among authors: mcgarry tf. Cardiovasc Revasc Med. 2011 Jul-Aug;12(4):247-57. doi: 10.1016/j.carrev.2010.09.008. Epub 2010 Dec 3. Cardiovasc Revasc Med. 2011. PMID: 21130708